SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-000666
Filing Date
2019-03-14
Accepted
2019-03-14 17:21:44
Documents
55
Period of Report
2019-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pharmacyte_10q-013119.htm 10-Q 401192
2 CERTIFICATION pharmacyte_10q-ex3101.htm EX-31.1 8840
3 CERTIFICATION pharmacyte_10q-ex3102.htm EX-31.2 8827
4 CERTIFICATION pharmacyte_10q-ex3201.htm EX-32.1 4309
5 CERTIFICATION pharmacyte_10q-ex3202.htm EX-32.2 4271
  Complete submission text file 0001683168-19-000666.txt   2836461

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pmcb-20190131.xml EX-101.INS 531883
7 XBRL SCHEMA FILE pmcb-20190131.xsd EX-101.SCH 30956
8 XBRL CALCULATION FILE pmcb-20190131_cal.xml EX-101.CAL 35728
9 XBRL DEFINITION FILE pmcb-20190131_def.xml EX-101.DEF 151522
10 XBRL LABEL FILE pmcb-20190131_lab.xml EX-101.LAB 233033
11 XBRL PRESENTATION FILE pmcb-20190131_pre.xml EX-101.PRE 214629
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 333-68008 | Film No.: 19681964
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1